bone.jpgIPNews® – The Federal Circuit on Thursday shot down Hoffmann-La Roche Inc.’s appeal of a district court’s refusal to grant it a patent injunction stopping three generic drug makers from producing their own versions of Roche’s osteoporosis drug Boniva.

Roche could not prove it was likely to overcome Apotex Inc., Watson Pharmaceuticals Inc. and Mylan

pills.jpgIPNews® – Prescription giant Merck announced today that it lost its recent patent infringement battle against Canadian competitor Apotex. 

The Canadian company had been accused of illegally selling a copy of Merck’s popular nasal allergy drug Nasonex.  Rather than strictly denying the allegations, Apotex challenged the validity of the Nasonex patent.  To continue reading, click: